Excerpts from a recent article in Kauppalehti:
Cor Group is not satisfied with just the role of an investor, but is actively involved in the operations of its holdings.
According to Lindén, Silmäasema and Terveystalo are complemented by Cor Group’s other listed holding, the health technology company Nightingale Health, which sells and develops a blood analysis-based platform to reduce the risk of lifestyle diseases. Cor Group is Nightingale Health’s largest shareholder with a holding of just under 20 percent.
Terveystalo is a major customer of Nightingale Health. According to Lindén, Nightingale Health is a step forward in enabling diseases to be treated and identified more broadly.